
Biosite Incorporated
Free shipping on orders over $99 · 30-day returns
MODIFICATION TO TRIAGE B-TYPE NATRIURETIC PEPTIDE (BNP) TEST is an FDA 510(k)-cleared medical device (K032235) manufactured by Biosite Incorporated. This device is classified under the Clinical Chemistry specialty. FDA Device Class II (Special Controls) — moderate risk, requires 510(k) clearance. FDA clearance granted on January 27, 2004. Regulation: 8.